1.8800
-0.1400
(-6.93%)
At close: April 16 at 4:00:02 PM EDT
1.9500
+0.07
+(3.72%)
After hours: April 16 at 7:45:49 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,873
7,873
--
--
--
Cost of Revenue
7,078
7,078
--
--
--
Gross Profit
795
795
--
--
--
Operating Expense
593,422
593,422
99,822
119,734
93,318
Operating Income
-592,627
-592,627
-99,822
-119,734
-93,318
Net Non Operating Interest Income Expense
26,721
26,721
24,611
7,448
2,963
Other Income Expense
-2,033
-2,033
-591
8,087
3,507
Pretax Income
-567,939
-567,939
-75,802
-104,199
-86,848
Net Income Common Stockholders
-567,939
-567,939
-75,802
-104,199
-86,848
Diluted NI Available to Com Stockholders
-567,939
-567,939
-75,802
-104,199
-86,848
Basic EPS
-2.11
--
-0.35
-0.48
-0.44
Diluted EPS
-2.11
--
-0.35
-0.48
-0.44
Basic Average Shares
268,772
--
218,880
216,721
197,887
Diluted Average Shares
268,772
--
218,880
216,721
197,887
Total Operating Income as Reported
-592,627
-592,627
-99,822
-119,734
-93,318
Total Expenses
600,500
600,500
99,822
119,734
93,318
Net Income from Continuing & Discontinued Operation
-567,939
-567,939
-75,802
-104,199
-86,848
Normalized Income
-566,991
-566,991
-76,160
-113,158
-90,999
Interest Income
27,062
27,062
24,611
7,448
2,963
Interest Expense
341
341
--
--
--
Net Interest Income
26,721
26,721
24,611
7,448
2,963
EBIT
-567,598
-567,598
-75,802
-119,734
-93,318
EBITDA
-566,915
-566,915
-75,580
-119,535
-93,134
Reconciled Cost of Revenue
7,078
7,078
--
--
--
Reconciled Depreciation
683
683
222
199
184
Net Income from Continuing Operation Net Minority Interest
-567,939
-567,939
-75,802
-104,199
-86,848
Total Unusual Items Excluding Goodwill
-948
-948
358
8,959
4,151
Total Unusual Items
-948
-948
358
8,959
4,151
Normalized EBITDA
-565,967
-565,967
-75,938
-128,494
-97,285
12/31/2021 - 8/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLAY Relay Therapeutics, Inc.
2.6100
-5.43%
GOSS Gossamer Bio, Inc.
0.8301
+0.02%
DAWN Day One Biopharmaceuticals, Inc.
6.76
-5.98%
VIR Vir Biotechnology, Inc.
5.44
-3.29%
ARVN Arvinas, Inc.
7.65
+0.92%
RCKT Rocket Pharmaceuticals, Inc.
6.15
-5.82%
ABEO Abeona Therapeutics Inc.
4.8500
-1.42%
UNCY Unicycive Therapeutics, Inc.
0.5980
+0.74%
IDYA IDEAYA Biosciences, Inc.
16.18
-4.71%
IOVA Iovance Biotherapeutics, Inc.
3.0700
-4.95%